Rationale and design of ON-TRK: a novel prospective non-interventional study in patients with TRK fusion cancer treated with larotrectinib

  1. Yang, J.C.H.
  2. Brose, M.S.
  3. Castro, G.
  4. Kim, E.S.
  5. Lassen, U.N.
  6. Leyvraz, S.
  7. Pappo, A.
  8. López-Ríos, F.
  9. Reeves, J.A.
  10. Fellous, M.
  11. Penault-Llorca, F.
  12. Rudzinski, E.R.
  13. Tabatabai, G.
  14. Vassal, G.
  15. Drilon, A.
  16. Trent, J.
Revista:
BMC Cancer

ISSN: 1471-2407

Ano de publicación: 2022

Volume: 22

Número: 1

Tipo: Artigo

DOI: 10.1186/S12885-022-09687-X GOOGLE SCHOLAR lock_openAcceso aberto editor